癫痫儿童药物治疗后复发的危险因素及预防对策分析

doi:10.3969/j.issn.1671-7171.2024.12.028

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1248 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the risk factors of relapse in children with epilepsy after drug treatment. 【Methods】The clinical data of 90 children with epilepsy admitted to our hospital from May 2020 to May 2021 were retrospectively analyzed, and they were divided into the observation group (children with relapse) and the control group (children without relapse) according to the recurrence of epilepsy after drug treatment. Logistic multivariate regression analysis was used to investigate the independent risk factors of relapse after drug treatment in children with epilepsy. 【Results】There were 24 cases of recurrence in 90 cases, the recurrence rate was 26.67%. Univariate analysis showed that there were statistically significant differences in age, frequency of onset, type of disease, duration of epilepsy, intracranial lesions and seizure free time before drug withdrawal between the two groups (P<0.05). Multivariate Logistic regression analysis showed that age (< 2 years), duration of disease before treatment ( >1 year), duration of drug withdrawal (< 6 months), and ECG after drug withdrawal showed that epileptic discharge were independent risk factors for relapse after drug treatment in children with epilepsy (P<0.05). 【Conclusion】 Age, course of disease before treatment, duration of drug withdrawal, eclamptic discharge shown by ECG after drug withdrawal are important risk factors for relapse in children with epilepsy after drug treatment. Clinical preventive measures can be taken according to risk factors to reduce the recurrence rate of epilepsy after drug treatment and improve the quality of life of children with epilepsy.

Key words： Epilepsy Drug Therapy Recurrence Risk Factors Child

Received: 21 August 2023

PACS:

R742.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Yanyan
	ZHANG Xiaoli
	DAI Dongqing
	et al

Cite this article:

LI Yanyan,ZHANG Xiaoli,DAI Dongqing, et al. Analysis of Risk Factors and Preventive Measures of Relapse in Children with Epilepsy after Drug Treatment[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(12): 1924-1926.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.12.028 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I12/1924

[1] 章飞霞,卢洪珠,刘玲,等. 61例青春前期癫痫患儿减药、停药复发的危险因素分析[J].福建医科大学学报,2020,54(4):238-242.
[2] 张洪伟, 金瑞峰, 刘勇,等. KCNT1基因变异致夜间额叶癫痫的诊治特点(附1例报告)[J].山东医药, 2020, 60(16):69-71.
[3] CHANG F M, FAN P C, WENG W C, et al. The efficacy of perampanel in young children with drug-resistant epilepsy[J].Seizure,2020,75:82-86.
[4] 张姗,盛桂梅,朱应红,等. 儿童癫痫主要照顾者院外护理服务需求的质性研究[J].齐鲁护理杂志,2020,26(13):13-16.
[5] 孟丽萍,戴园园. 儿童睡眠中癫痫性电持续状态的临床分析及甲泼尼龙冲击治疗的随访研究[J].中国当代儿科杂志,2019,21(4):348-353.
[6] 师睿,阴怀清,王转转. 左乙拉西坦与苯妥英作为二线用药治疗儿童惊厥性癫痫持续状态的有效性及安全性的Meta分析[J].中国当代儿科杂志,2021,23(4):356-362.
[7] TSAI S Y, LEE W T, LEE C C, et al. Sleep in mothers of children with epilepsy and its relation to their children's sleep[J].Res Nurs Health,2020,43(2):168-175.
[8] 王慧玲,张涛志,尹续续,等.WHO儿童基本药物目录与国家基本药物目录中的抗癫痫药对比分析[J].中国药房,2020,31(20):2452-2457.
[9] 胡湛棋,曾洪武,廖建湘,等.静息态功能磁共振对伴中央颞区棘波的儿童良性癫痫认知功能变化的研究[J].中华实用儿科临床杂志,2020,35(4):285-288.
[10] 董春娟,蔡榕,陈清秀.生酮饮食联合延续性护理对儿童难治性癫痫的治疗及护理研究[J].护士进修杂志,2020,35(22):2044-2048.
[11] 张玉珍,尹秋凤,郑慧,等.DTI各向异性分数与椭球面积比在儿童特发性全面性癫痫中的比较研究[J].放射学实践,2020,35(12):1589-1594.
[12] JESCHKE S, WOLTERMANN S, NEININGER M P, et al.Why do children and adolescents with epilepsy disclose or not disclose their condition to their friends?[J].Eur J Pediatr,2020,179(10):1627-1633.
[13] 夏顺刚,卢红. 奥卡西平对儿童病毒性脑炎继发癫痫患者的炎性因子、免疫功能及氧化应激的影响[J].中国免疫学杂志,2019,35(9):1122-1125.
[14] 邓劼,方方,王晓慧,等. GATOR1复合物基因变异致儿童局灶性癫痫的临床及遗传学特点分析[J].中华儿科杂志,2019,57(10):780-785.
[15] 胡琳,金海华.左乙拉西坦治疗儿童难治性癫痫的疗效及对血清IgA、IgM和IgG水平的影响[J].中国妇幼保健,2019,34(22):5233-5235.